| __timestamp | Alnylam Pharmaceuticals, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 55402000 |
| Thursday, January 1, 2015 | 41097000 | 66107000 |
| Friday, January 1, 2016 | 47159000 | 103402000 |
| Sunday, January 1, 2017 | 76545000 | 135736000 |
| Monday, January 1, 2018 | 73106000 | 245116000 |
| Tuesday, January 1, 2019 | 194688000 | 108935000 |
| Wednesday, January 1, 2020 | 414801000 | 156000000 |
| Friday, January 1, 2021 | 704143000 | 214957000 |
| Saturday, January 1, 2022 | 868601000 | 143418000 |
| Sunday, January 1, 2023 | 1517886000 | 96265000 |
| Monday, January 1, 2024 | 1924873000 |
Unleashing insights
In the competitive world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Alnylam Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated have been vying for dominance in gross profit generation. From 2014 to 2023, Alnylam has shown a remarkable growth trajectory, with its gross profit surging by over 2,900%, reaching a peak in 2023. In contrast, Ligand's growth has been more modest, with a peak in 2018 and a subsequent decline, ending 2023 with a gross profit of just 39% of its 2018 high. This stark contrast highlights Alnylam's strategic advancements and market positioning, making it a formidable player in the biotech industry. As investors and industry watchers look to the future, Alnylam's upward trend suggests a promising path ahead, while Ligand may need to reassess its strategies to regain momentum.
Gross Profit Analysis: Comparing Eli Lilly and Company and Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Ligand Pharmaceuticals Incorporated Trends
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Key Insights on Gross Profit: Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.
Alnylam Pharmaceuticals, Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc. Trends
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Comparison: Genmab A/S and Ligand Pharmaceuticals Incorporated Trends
Gross Profit Trends Compared: Viatris Inc. vs Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Bio-Techne Corporation vs Ligand Pharmaceuticals Incorporated